Aiqin Wang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Aiqin Wang has a total of 3 co-authors. Here are the top co-authors by number of shared publications:
- Guowei Zhao
Department of Dermatology, Zibo Central Hospital, Zibo, China
1 shared publication - Hui Wang
Department of Dermatology ZiBo Central Hospital Zibo China
1 shared publication - Yan Li
Department of Dermatology, ZiBo Central Hospital, No 54 Gongqingtuan West Road, Zibo, Shangdong, 255036, China
1 shared publication
Latest Publications
- 13 October 2023
- Published by Wiley in The Journal of Dermatology
- Vol. 51 (1) , 140-144
Dermato‐neuro syndrome after COVID‐19 infection in a patient with scleromyxoedema: Previously successful treatment with intravenous immunoglobulins
Scleromyxedema (SMX) is a rare disease of unknown cause. It is a chronic, progressive, metabolic disorder characterized by a generalized papular and scleroderma-like rash, as well as a subtype of lichen myxedematosus. Dermato-neuro syndrome (DNS) is a rare neurological complication of SMX. It has flu-like prodromal symptoms; consists of a triad of fever, coma, and seizures; and can be life-threatening. We describe a patient with SMX complicated by DNS after infection with COVID-19. Her symptoms resolved after treatment with acyclovir and low-dose glucocorticoids, suggesting that DNS seizures may have a viral cause. Her skin lesions also improved after seven courses of intravenous immunoglobulin treatment, confirming that intravenous immunoglobulin is effective in these cases.
- 13 October 2023
- Published by Wiley in The Journal of Dermatology
- Vol. 51 (1) , 140-144
Dermato‐neuro syndrome after COVID‐19 infection in a patient with scleromyxoedema: Previously successful treatment with intravenous immunoglobulins
Scleromyxedema (SMX) is a rare disease of unknown cause. It is a chronic, progressive, metabolic disorder characterized by a generalized papular and scleroderma-like rash, as well as a subtype of lichen myxedematosus. Dermato-neuro syndrome (DNS) is a rare neurological complication of SMX. It has flu-like prodromal symptoms; consists of a triad of fever, coma, and seizures; and can be life-threatening. We describe a patient with SMX complicated by DNS after infection with COVID-19. Her symptoms resolved after treatment with acyclovir and low-dose glucocorticoids, suggesting that DNS seizures may have a viral cause. Her skin lesions also improved after seven courses of intravenous immunoglobulin treatment, confirming that intravenous immunoglobulin is effective in these cases.